Parkinson’s disease - search results

Alberto Mantovani, Istituto Superiore di Sanità looks at how the adverse outcome pathway concept is the long way from molecular to adversity

Open Access Governments Editor Laura Evans talks to NIDCD’s Deputy Director Dr Judith Cooper about the research strides being made in speech and language disorders The National Institute on Deafness and Other Communication Disorders (NIDCD), part of the National Institutes of Health (NIH), reports that nearly 1 in 12 children...

Antonino Tramonte, Managing Director, Swiss Institute for Regenerative Medicine outlines how regenerative medicine can help patients.

The changing pharma landscape means opportunities for Parkinson's drug discovery are missed, but Parkinson's UK has a new strategy to redress the balance This will be the 200th year since James Parkinson wrote his seminal paper on ‘the Shaking Palsy’. Since that time there have been major developments in the...

Duncan McHale, Vice President, Head of Global Early Development at UCB highlights new therapies for neurodegenerative diseases such as Alzheimer’s disease… Neurodegenerative diseases are a growing global challenge as medical advances ensures more individuals live longer.  By 2020 there will be more than 40 million individuals in the world with...

The Clinic of Nuclear Medicine at the University Hospital is located both in Düsseldorf and at the Research Center Jülich, and runs a nuclear medical out-patient department covering the whole spectrum of radioisotope scanning from thyroid and skeleton scintigraphy to examinations of amino acid metabolism for tumor diagnosis. As...

Energy defects, neuroinflammatory processes, and abnormal cellular morphology in neurodegenerative diseases (ND) would constitute extremely informative brain imaging biomarkers of disease progression and readouts in clinical trials. Emerging research aims at developing novel brain imaging methods to study these different aspects not only in animal models but also in...

With the growing burden of brain disorders, it is more important than ever to ensure the necessary approaches are available; the European Brain Council discusses the priorities for supporting brain health and research in Europe and beyond.

Non-Human primates (NHPs) continue to be fundamentally necessary to advance our understanding of the human brain, from its molecular and cellular make up all the way to its systems architecture and how all these mesmerizing components give rise to behavior. This necessity is not changing. It is the curiosity and effort of the human brain to understand itself.

Effective treatments for amyloid-associated neurological diseases are desperately needed; H. Robert Guy, CEO of Amyloid Research Consultants, talks us through the obstacles and opportunities associated with structure-based drug design.

Dr. Huttunen has a Ph.D. degree in biochemistry and has previously held research positions at the University of Helsinki, Massachusetts General Hospital, Harvard Medical School and Orion Pharma. He is one of co-founders of Herantis Pharma Plc, listed in the NASDAQ Helsinki Stock Exchange First North marketplace, and has served...

In a current incontinence treatment, researchers are exploring how to physically regulate bladder function by bioelectrical implant signals.

Low-Intensity Focused Ultrasound (LIFU) is an emerging neuromodulation method for treating major depressive disorder which allows for non-invasive stimulation across the whole brain.

Phillip Anderson, Head of Policy at the MS Society UK, describes the need to improve multiple sclerosis treatment, care & support, including access to disease modifying therapies.

Prof Chris Barnes & Dr Jack Rutter share a future vision for microbiome engineering - harnessing the microbiome’s role in health & disease

Health charities have come into collaboration with the government and the NHS to promote and advance vaccine update, as UK hits its next milestone in the vaccine rollout.

Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.

Andreas Met, COO, Compliance and Director at Halo Labs highlights how the use of medical cannabis is on the rise in the UK and could offer relief to many NHS patients.

In the current moment, how severely is the viral misinformation online (from anti-vaccination movements to deadly 'miracle' cures) impacting the medical industry?

Patients will benefit from significant government investment in new NHS technology to improve treatment, diagnosis and care options for diseases including cancer.